DreaMed

3 stories about DreaMed
עובדי דרימד DreaMed

Israeli startup DreaMed gets FDA approval for app that adjusts insulin doses for Type 2 diabetes

28.09.26|Meir Orbach
MODI analyzes glucose and treatment data to provide personalized dosage recommendations between doctor visits without requiring approval for each adjustment. 
DreaMed team

DreaMed secures $3M and strategic deals amid CEO's reserve IDF duty

19.08.24|CTech
The AI ​​solution developed by DreaMed is designed to provide treatment recommendations to millions of people with diabetes who do not have access to endocrinologists.  
Eran Agmon  DreaMed

Did you know code can kill?

24.05.22|Eran Agmon
The conversation on system bugs can start with user experience and data but can very quickly reach human life, writes Eran Agmon, Chief Product Officer at DreaMed